3 Stocks That Could Be Monster Winners in 2024
Finding stocks that are huge winners is easy, in retrospect. Doing so before they take off is an entirely different story. However, it's not an impossible task.
Three Motley Fool contributors think they've identified stocks that could be monster winners in 2024. Here's why they picked CRISPR Therapeutics (NASDAQ: CRSP), Madrigal Pharmaceuticals (NASDAQ: MDGL), and Verona Pharma (NASDAQ: VRNA).
Prosper Junior Bakiny (CRISPR Therapeutics): It's been a great year for the field of gene editing. Several companies that specialize in this area have made important progress. However, the most significant milestone arguably came from CRISPR Therapeutics, which, together with its partner Vertex Pharmaceuticals, earned approval for Casgevy.
Source Fool.com
Vertex Pharmaceuticals Inc. Aktie
Vertex Pharmaceuticals Inc. ist ein klarer Community-Favorit mit mehr Buy- als Sell-Einschätzungen.
Trotz eines Kursziels von 440 €, das unter 452.85 € liegt, ergibt sich für Vertex Pharmaceuticals Inc. ein negatives Potenzial von -2.84%.
